Seelos Therapeutics Provides Update on Top-Line Results from its Amyotrophic Lateral Sclerosis (ALS) Study with SLS-005 (IV Trehalose)
Stock Information for Seelos Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.